1. World Health Organization. Congenital anomalies. Fact sheet No 370. October 2012 ( icon, accessed 11 February 2014).
  2. Resolution WHA63.17. Birth defects. In: Sixty-third World Health Assembly, Geneva, 17–21 May 2010. Geneva: World Health Organization; 2010 ( pdf icon[PDF – 15KB]external icon, accessed 11 February 2014).
  3. Thacker SB, Berkelman RL. History of public health surveillance. In: Halperin W, Baker EL, editors. Public health surveillance. New York: Van Norstrand Reinhold; 1992:1–15.
  4. Centers for Disease Control and Prevention. Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR Morb. Mortal. Wkly. Rep. 2001;50(RR- 13):1–30 (, accessed 11 February 2014).
  5. Surveillance of antiretroviral drug toxicity in pregnancy and breastfeeding. Geneva: World Health Organization; 2013 ( icon, accessed 11 February 2014).
  6. California Department of Public Health. Birth defect information
  7. Maternal Child and Adolescent Health Division, Center for Family Planning, California Department of Public Health. California Birth Defects Monitoring Program data. Overall rates of select birth defects – Central Valley counties.
  8. Annual report 2012. Rome: International Clearinghouse for Birth Defects, Surveillance and Research; 2013
  9. Alberta Congenital Anomalies Surveillance System. Seventh report 1980–2005. Edmonton: Alberta Health and Wellness; 2007
  10. Utah Department of Health. Utah’s indicator-based information system for public health ( icon, accessed 11 February 2014).
  11. Report of the Birth Defects Registry of Western Australia 1980–2009. Subiaco, WA: King Edward Memorial Hospital; 2010
  12. International statistical classification of diseases and related health problems, 10th revision. Geneva: World Health Organization; 2010 ( icon, accessed 11 February 2014).
  13. Bower C, Rudy E, Callaghan A, Quick J, Nassar N. Age at diagnosis of birth defects. Birth Defects Res. A Clin. Mol. Teratol. 2010;88(4):251–5. doi:10.1002/bdra.20658.
  14. Sever LE, editor. Guidelines for conducting birth defects surveillance. Atlanta, GA: National Birth Defects Prevention Network, Inc., 2001.
  15. Gonçalves-Leite IC, Koifman S. Oral clefts, consanguinity, parental tobacco and alcohol use: a case-control study in Rio de Janeiro, Brazil. Braz. Oral Res. 2009;23:31–7.
  16. Khalid Y, Ghina M, Fadi B, Fadi C, May K, Joseph R et al. Consanguineous marriage and congenital heart defects: A case-control study in the neonatal period. Am. J. Med. Genet. A. 2006;140A:1524–30.
  17. Nabulsi MM, Tamim H, Sabbagh M, Obeid MY, Yunis KA, Bitar FF. Parental consanguinity and congenital heart malformations in a developing country. Am. J. Med. Genet. A. 2003;116A:342–7.
  18. Ramegowda S, Ramachandra NB. Parental consanguinity increases congenital heart diseases in South India. Ann. Hum. Biol. 2006;33:519–28.
  19. Ravichandran K, Shoukri M, Aljohar A, Shazia NS, Al-Twaijri Y, Al Jarba I. Consanguinity and occurrence of cleft lip/palate: A Hospital-Based Registry Study in Riyadh. Am. J. Med. Genet. A. 2012;158A:541–6. doi:10.1002/ ajmg.a.34432.
  20. Rittler M, Liascovich R, Lopez-Camelo J, Castilla EE. Parental consanguinity in specific types of congenital anomalies. Am. J. Med. Genet. A. 2001;102A:36–43.
  21. Shieh JTC, Bittles AH, Hudgins L. Consanguinity and the risk of congenital heart disease. Am. J. Med. Genet. A. 2012;158A:1236–41. doi:10.1002/ajmg.a.35272.
  22. Siegfried N, Clarke M, Volmink J. Randomised controlled trials in Africa of HIV and AIDS: descriptive study and spatial distribution. BMJ. 2005;331:742–6.
  23. Seebregts CJ, Zwarenstein M, Mathews C, Fairall L, Flisher AJ, Seebregts C et al. Handheld computers for survey and trial data collection in resource-poor settings: development and evaluation of PDACT, a Palm Pilot interviewing system. International. J. Med. Inform. 2009;78;721–31. doi:10.1016/j.ijmedinf.2008.10.006.
  24. DeRenzi B, Borriello G, Jackson J, Kumar VS, Parikh TS, Virk P et al. Mobile phone tools for field-based health care workers in low-income countries. Mt. Sinai J. Med. 2011;78:406–18. doi:10.1002/msj.20256.
  25. De Nicola PD, Cernach MC, Perez AB, Brunoni D. Use of internet to report congenital malformations on birth defects at four public maternity hospitals in the city of Sao Paulo, Brazil. Cad. Saude Publica. 2010;26(7):1383–90.
  26. Mehta U, Clerk C, Allen E, Yore M, Sevene E, Singlovic J et al. Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings. BMC Pregnancy Childbirth. 2012;12:89. doi:10.1186/1471-2393-12-89.
  27. Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural tube defects. N. Engl. J. Med. 1999;341:1509–19.
  28. Rojvachiranonda N, David DJ, Moore MH, Cole J. Frontoethmoidal encephalomeningocele: new morphological findings and a new classification. J. Craniofacial Surg. 2003;14:847–58.
  29. Miedzybrodzka Z. Congenital talipes equinovarus (clubfoot): a disorder of the foot but not the hand. J. Anat. 2003;202:37–42.
  30. Umaña LA, Magoulas P, Bi W, Bacino CA. A male newborn with VACTERL association and Fanconi anemia with a FANCB deletion detected by array comparative genomic hybridization (aCGH). Am. J. Med. Genet. A. 2011;155:3071–4. doi:10.1002/ajmg.a.34296
  31. Biesecker LG, Aase JM, Clericuzio C, Gurrieri F, Temple IK, Toriello H. Elements of morphology: standard terminology for the hands and feet. Am. J. Med. Genet. A. 2009;149A:93–127. doi:10.1002/ajmg.a.32596.
  32. Contact points for the 42 language versions of ICD-10 ( pdf icon[PDF – 82KB]external icon, accessed 11 February 2014).
  33. World Health Organization. ICD-10 interactive self learning tool ( icon, accessed 11 February 2014).
  34. The Royal College of Paediatrics and Child Health adaptation of the International Statistical Classification of Diseases and Health Related Problems, 10th revision. London: Royal College of Paediatrics and Child Health; 2001.
  35. Martínez-Frías ML, Bermejo E, Frías JL. Pathogenetic classification of a series of 27,145 consecutive infants with congenital defects. Am. J. Med. Genet. 2000;90:246–9.
  36. Garne E, Dolk H, Loane M, Wellesley D, Barisic I, Calzolari E et al.; EUROCAT Working Group. Paper 5: Surveillance of multiple congenital anomalies: implementation of a computer algorithm in European registers for classification of cases. Birth Defects Res. A Clin. Mol. Teratol. 2011;91(Suppl. 1):S44–50. doi:10.1002/bdra.20777.
  37. International Clearinghouse for Birth Defects (www.icbdsr.orgexternal icon, accessed 11 February 2014).
  38. National Birth Defects Prevention Network (www.nbdpn.orgexternal icon, accessed 11 February 2014).
  39. EUROCAT: European surveillance of congenital anomalies (www.eurocat-network.euexternal icon, accessed 11 February 2014).
  40. OMIM: Online Mendelian Inheritance in Man (,external icon or icon, accessed 11 February 2014).
  41. Stevenson RE, Hall JG, editors. Human malformations and related anomalies, 2nd ed. Oxford: Oxford University Press; 2006.
  42. Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, Nygren K et al. International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology. Fertil. Steril. 2009;92:1520–4.
  43. O’Toole M. Miller-Keane encyclopedia and dictionary of medicine, nursing and allied health, 7th ed. Philadelphia: WB Saunders; 2003.
  44. Nelson K, Holmes LB. Malformations due to presumed spontaneous mutations in newborn infants. N. Engl. J. Med. 1989;320:19–23.
  45. Brent RL. Environmental causes of human congenital malformations: the pediatrician’s role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors. Pediatrics. 2004;113:957–68.
  46. Mother to baby. Medications and more during pregnancy and breastfeeding. Ask the experts. Fact sheets (, accessed 11 February 2014).
  47. Mossey PA, Little J, Munger RG, Dixon MJ, Shaw WC. Cleft lip and palate. Lancet. 2009;374:1773–85.
  48. Wlodarczyk BJ, Palacios AM, George TM, Finnell RH. Antiepileptic drugs and pregnancy outcomes. Am. J. Med. Genet. A 2012; 158A:2071–90. doi:10.1002/ajmg.a.35438.
  49. Vissers LE, van Ravenswaaij CM, Admiraal R, Hurst JA, de Vries BB, Janssen IM et al. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat. Genet. 2004;36:955–97.
  50. Rasmussen SA, Olney RS, Holmes LB, Lin AE, Keppler-Noreuil KM, Moore CA. National Birth Defects Prevention Study. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res. A Clin. Mol. Teratol. 2003;67:193–201.
  51. Mokdad AH, Annest JL, Ikeda RM, Mai CT. Public health surveillance for chronic diseases, injuries, and birth defects. In: Lee LM, Teutsch SM, Thacker SB, St Louis ME, editors. Principles and practice of public health surveillance. Oxford: Oxford University Press; 2010:255–74.
  52. Sheets BK, Crissman BG, Feist CD, Sell SL, Johnson LR, Donahue KC, et al. Practice guidelines for communicating a prenatal or postnatal diagnosis of Down syndrome: recommendations of the National Society of Genetic Counselors. J. Genet. Counsel. 2011;20:432–41. doi:10.1007/s10897-011-9375-8.
  53. Annual report 2008 with data for 2006. Rome: International Clearinghouse for Birth Defects, Surveillance and Research; 2008.

 Top of Page